Nitroglycerin Patent Expiration
Nitroglycerin was first introduced by Hospira Inc
Nitroglycerin Patents
Given below is the list of patents protecting Nitroglycerin, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Gonitro | US9101592 | Stabilized granules containing glyceryl trinitrate | Mar 11, 2032 | Pohl Boskamp |
| Nitrolingual Pumpspray | US7872049 | Long-term stable pharmaceutical preparation containing the active ingredient glyceryl trinitrate | Mar 12, 2029 | Pohl Boskamp |
| Nitrostat | US6500456 | Compressed nitroglycerin tablet and its method of manufacture |
Sep 16, 2018
(Expired) | Viatris |
| Nitromist | US5869082 | Buccal, non-polar spray for nitroglycerin |
Apr 16, 2016
(Expired) | Evus |
| Rectiv | US7189761 | Nitric oxide donor composition and method for treatment of anal disorders |
May 27, 2014
(Expired) | Abbvie |
A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Nitroglycerin's patents.
Latest Legal Activities on Nitroglycerin's Patents
Given below is the list recent legal activities going on the following patents of Nitroglycerin.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Expire Patent Critical | 15 Apr, 2019 | US7189761 |
| Maintenance Fee Reminder Mailed Critical | 29 Oct, 2018 | US7189761 |
| Recordation of Patent Grant Mailed Critical | 13 Mar, 2007 | US7189761 |
| Patent Issue Date Used in PTA Calculation Critical | 13 Mar, 2007 | US7189761 |
| Issue Notification Mailed Critical | 21 Feb, 2007 | US7189761 |
| Application Is Considered Ready for Issue Critical | 30 Jan, 2007 | US7189761 |
| Dispatch to FDC | 30 Jan, 2007 | US7189761 |
| Issue Fee Payment Verified Critical | 26 Jan, 2007 | US7189761 |
| Issue Fee Payment Received Critical | 26 Jan, 2007 | US7189761 |
| Mail Notice of Allowance Critical | 30 Oct, 2006 | US7189761 |
Nitroglycerin's Family Patents
Explore Our Curated Drug Screens
Nitroglycerin Generic API Manufacturers
Several generic applications have been filed for Nitroglycerin. The first generic version for Nitroglycerin was by International Medication Systems Ltd and was approved on Sep 10, 1985. And the latest generic version is by Viwit Pharmaceutical Co Ltd and was approved on Oct 15, 2024.
Given below is the list of companies who have filed for Nitroglycerin generic, along with the locations of their manufacturing plants worldwide.
1. ABRAXIS PHARM
Abraxis Pharmaceutical Products has filed for 1 generic for Nitroglycerin. Given below are the details of the strengths of this generic introduced by Abraxis Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG/ML | injectable | Discontinued | INJECTION | N/A | May 8, 1987 |
2. ACTAVIS LABS FL INC
Actavis Laboratories Fl Inc has filed for 3 different strengths of generic version for Nitroglycerin. Given below are the details of the strengths of this generic introduced by Actavis Labs Fl Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4MG | tablet | Discontinued | SUBLINGUAL | N/A | Oct 16, 2017 |
| 0.3MG | tablet | Discontinued | SUBLINGUAL | N/A | Oct 16, 2017 |
| 0.6MG | tablet | Discontinued | SUBLINGUAL | N/A | Oct 16, 2017 |
3. AM REGENT
American Regent Inc has filed for 1 generic for Nitroglycerin. Given below are the details of the strengths of this generic introduced by Am Regent.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG/ML
(reference standard) | injectable | Prescription | INJECTION | N/A | May 24, 1988 |
4. AUROBINDO PHARMA
Aurobindo Pharma Ltd has filed for 3 different strengths of generic version for Nitroglycerin. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4MG | tablet | Prescription | SUBLINGUAL | AB | Oct 26, 2023 |
| 0.3MG | tablet | Prescription | SUBLINGUAL | AB | Oct 26, 2023 |
| 0.6MG | tablet | Prescription | SUBLINGUAL | AB | Oct 26, 2023 |
Manufacturing Plant Locations New
Aurobindo Pharma's manufacturing plants are situated in 2 countries - India, United States. Given below are the details of these plant locations as well as the firm names of Aurobindo Pharma as present at those locations.
| Country | City | Firm Name | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||
| United States |
| |||||||||
5. BAUSCH
Bausch Health Us Llc has filed for 1 generic for Nitroglycerin. This 0.4mg/hr version comes by the name MINITRAN. Given below are the details of the strengths of this generic introduced by Bausch.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4MG/HR | film, extended release | Discontinued | TRANSDERMAL | N/A | Aug 30, 1996 |
Manufacturing Plant Locations New
Bausch's manufacturing plants are situated in 2 countries - United States, Canada. Given below are the details of these plant locations as well as the firm names of Bausch as present at those locations.
| Country | City | Firm Name | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United States |
| |||||||||||||||||||||||||||
| Canada |
| |||||||||||||||||||||||||||
6. COSETTE
Cosette Pharmaceuticals Inc has filed for 1 generic for Nitroglycerin. Given below are the details of the strengths of this generic introduced by Cosette.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4% | ointment | Prescription | INTRA-ANAL | AB | Feb 16, 2024 |
Manufacturing Plant Locations New
Cosette's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Cosette as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
7. DR REDDYS
Dr Reddys Laboratories Inc has filed for 3 different strengths of generic version for Nitroglycerin. Given below are the details of the strengths of this generic introduced by Dr Reddys.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4MG | tablet | Prescription | SUBLINGUAL | AB | Aug 26, 2016 |
| 0.6MG | tablet | Prescription | SUBLINGUAL | AB | Aug 26, 2016 |
| 0.3MG | tablet | Prescription | SUBLINGUAL | AB | Aug 26, 2016 |
8. FOUGERA PHARMS INC
Fougera Pharmaceuticals Inc has filed for 1 generic for Nitroglycerin. Given below are the details of the strengths of this generic introduced by Fougera Pharms Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 2%
(reference standard) | ointment | Prescription | TRANSDERMAL | N/A | Jul 8, 1988 |
9. GLENMARK SPECLT
Glenmark Specialty Sa has filed for 3 different strengths of generic version for Nitroglycerin. Given below are the details of the strengths of this generic introduced by Glenmark Speclt.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.3MG | tablet | Prescription | SUBLINGUAL | AB | Sep 19, 2017 |
| 0.4MG | tablet | Prescription | SUBLINGUAL | AB | Sep 19, 2017 |
| 0.6MG | tablet | Prescription | SUBLINGUAL | AB | Sep 19, 2017 |
10. HOSPIRA
Hospira Inc has filed for 4 different strengths of generic version for Nitroglycerin. All of these versions come by the name NITROGLYCERIN IN DEXTROSE 5%. Given below are the details of the strengths of this generic introduced by Hospira.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 20MG/100ML | injectable | Discontinued | INJECTION | N/A | Aug 31, 1990 |
| 10MG/100ML | injectable | Discontinued | INJECTION | N/A | Aug 31, 1990 |
| 40MG/100ML | injectable | Discontinued | INJECTION | N/A | Aug 31, 1990 |
| 0.1MG/ML | injectable | Discontinued | INJECTION | N/A | Oct 26, 1994 |
Manufacturing Plant Locations New
Hospira's manufacturing plants are situated in 3 countries - Australia, United States, Dominican Republic (the). Given below are the details of these plant locations as well as the firm names of Hospira as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Australia |
| |||||||||||||
| United States |
| |||||||||||||
| Dominican Republic (the) |
| |||||||||||||
11. INTL MEDICATION
International Medication Systems Ltd has filed for 1 generic for Nitroglycerin. Given below are the details of the strengths of this generic introduced by Intl Medication.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG/ML | injectable | Discontinued | INJECTION | N/A | Sep 10, 1985 |
12. LANNETT CO INC
Lannett Co Inc has filed for 2 different strengths of generic version for Nitroglycerin. Given below are the details of the strengths of this generic introduced by Lannett Co Inc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4MG/HR | film, extended release | Discontinued | TRANSDERMAL | N/A | Aug 10, 2004 |
| 0.2MG/HR | film, extended release | Discontinued | TRANSDERMAL | N/A | Aug 10, 2004 |
13. LUITPOLD
Luitpold Pharmaceuticals Inc has filed for 1 generic for Nitroglycerin. Given below are the details of the strengths of this generic introduced by Luitpold.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG/ML | injectable | Discontinued | INJECTION | N/A | May 24, 1988 |
14. MANKIND PHARMA
Mankind Pharma Ltd has filed for 3 different strengths of generic version for Nitroglycerin. Given below are the details of the strengths of this generic introduced by Mankind Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4MG | tablet | Prescription | SUBLINGUAL | AB | Dec 5, 2023 |
| 0.3MG | tablet | Prescription | SUBLINGUAL | AB | Dec 5, 2023 |
| 0.6MG | tablet | Prescription | SUBLINGUAL | AB | Dec 5, 2023 |
Manufacturing Plant Locations New
Mankind Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Mankind Pharma as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| India |
| |||||
15. MYLAN TECHNOLOGIES
Mylan Technologies Inc has filed for 4 different strengths of generic version for Nitroglycerin. Given below are the details of the strengths of this generic introduced by Mylan Technologies.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4MG/HR | film, extended release | Discontinued | TRANSDERMAL | N/A | Nov 12, 1999 |
| 0.2MG/HR | film, extended release | Discontinued | TRANSDERMAL | N/A | Nov 12, 1999 |
| 0.6MG/HR | film, extended release | Discontinued | TRANSDERMAL | N/A | Nov 12, 1999 |
| 0.1MG/HR | film, extended release | Discontinued | TRANSDERMAL | N/A | Nov 12, 1999 |
Manufacturing Plant Locations New
Mylan Technologies's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Mylan Technologies as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
16. NATCO
Natco Pharma Ltd has filed for 3 different strengths of generic version for Nitroglycerin. Given below are the details of the strengths of this generic introduced by Natco.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.6MG | tablet | Prescription | SUBLINGUAL | AB | Apr 30, 2019 |
| 0.4MG | tablet | Prescription | SUBLINGUAL | AB | Apr 30, 2019 |
| 0.3MG | tablet | Prescription | SUBLINGUAL | AB | Apr 30, 2019 |
Manufacturing Plant Locations New
Natco's manufacturing plants are situated in 2 countries - United Kingdom, India. Given below are the details of these plant locations as well as the firm names of Natco as present at those locations.
| Country | City | Firm Name | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| United Kingdom |
| |||||||||||||
| India |
| |||||||||||||
17. PADAGIS ISRAEL
Padagis Israel Pharmaceuticals Ltd has filed for 1 generic for Nitroglycerin. Given below are the details of the strengths of this generic introduced by Padagis Israel.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.4MG/SPRAY | spray, metered | Prescription | SUBLINGUAL | AB | Sep 20, 2013 |
Manufacturing Plant Locations New
Padagis Israel's manufacturing plants are situated in 1 country - Israel. Given below are the details of these plant locations as well as the firm names of Padagis Israel as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| Israel |
| |||
18. PARKE DAVIS
Parke Davis Div Warner Lambert Co has filed for 2 different strengths of generic version for Nitroglycerin. All of these versions come by the name NITROSTAT. Given below are the details of the strengths of this generic introduced by Parke Davis.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG/ML | injectable | Discontinued | INJECTION | N/A | Jan 8, 1987 |
| 5MG/ML | injectable | Discontinued | INJECTION | N/A | Jan 8, 1987 |
19. RUBICON
Rubicon Research Private Ltd has filed for 3 different strengths of generic version for Nitroglycerin. Given below are the details of the strengths of this generic introduced by Rubicon.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.3MG | tablet | Prescription | SUBLINGUAL | AB | May 3, 2021 |
| 0.4MG | tablet | Prescription | SUBLINGUAL | AB | May 3, 2021 |
| 0.6MG | tablet | Prescription | SUBLINGUAL | AB | May 3, 2021 |
Manufacturing Plant Locations New
Rubicon's manufacturing plants are situated in 3 countries - United States, Canada, India. Given below are the details of these plant locations as well as the firm names of Rubicon as present at those locations.
| Country | City | Firm Name | ||||
|---|---|---|---|---|---|---|
| United States |
| |||||
| Canada |
| |||||
| India |
| |||||
20. SANOFI AVENTIS US
Sanofi Aventis Us Llc has filed for 1 generic for Nitroglycerin. This 10mg/ml version comes by the name NITRO-BID. Given below are the details of the strengths of this generic introduced by Sanofi Aventis Us.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 10MG/ML | injectable | Discontinued | INJECTION | N/A | Feb 28, 1990 |
21. SIGMAPHARM LABS LLC
Sigmapharm Laboratories Llc has filed for 3 different strengths of generic version for Nitroglycerin. Given below are the details of the strengths of this generic introduced by Sigmapharm Labs Llc.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.6MG | tablet | Discontinued | SUBLINGUAL | N/A | May 7, 2018 |
| 0.3MG | tablet | Discontinued | SUBLINGUAL | N/A | May 7, 2018 |
| 0.4MG | tablet | Discontinued | SUBLINGUAL | N/A | May 7, 2018 |
22. SMITH AND NEPHEW
Smith And Nephew Solopak Div Smith And Nephew has filed for 1 generic for Nitroglycerin. Given below are the details of the strengths of this generic introduced by Smith And Nephew.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 5MG/ML | injectable | Discontinued | INJECTION | N/A | Jun 19, 1986 |
Manufacturing Plant Locations New
Smith And Nephew's manufacturing plants are situated in 1 country - United States. Given below are the details of these plant locations as well as the firm names of Smith And Nephew as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| United States |
| |||
23. VALEANT PHARMS
Valeant Pharmaceuticals North America Llc has filed for 2 different strengths of generic version for Nitroglycerin. All of these versions come by the name MINITRAN. Given below are the details of the strengths of this generic introduced by Valeant Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.6MG/HR | film, extended release | Discontinued | TRANSDERMAL | N/A | Aug 30, 1996 |
| 0.1MG/HR | film, extended release | Discontinued | TRANSDERMAL | N/A | Aug 30, 1996 |
24. VALEANT PHARMS NORTH
Valeant Pharmaceuticals North America Llc has filed for 1 generic for Nitroglycerin. This 0.2mg/hr version comes by the name MINITRAN. Given below are the details of the strengths of this generic introduced by Valeant Pharms North.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.2MG/HR | film, extended release | Discontinued | TRANSDERMAL | N/A | Aug 30, 1996 |
25. VIWIT PHARM
Viwit Pharmaceutical Co Ltd has filed for 3 different strengths of generic version for Nitroglycerin. Given below are the details of the strengths of this generic introduced by Viwit Pharm.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.3MG | tablet | Prescription | SUBLINGUAL | AB | Oct 15, 2024 |
| 0.4MG | tablet | Prescription | SUBLINGUAL | AB | Oct 15, 2024 |
| 0.6MG | tablet | Prescription | SUBLINGUAL | AB | Oct 15, 2024 |
Manufacturing Plant Locations New
Viwit Pharm's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Viwit Pharm as present at those locations.
| Country | City | Firm Name | ||
|---|---|---|---|---|
| China |
| |||
26. ZYDUS PHARMS
Zydus Pharmaceuticals Usa Inc has filed for 7 different strengths of generic version for Nitroglycerin. Given below are the details of the strengths of this generic introduced by Zydus Pharms.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.6MG/HR | film, extended release | Prescription | TRANSDERMAL | AB2 | Oct 30, 1998 |
| 0.4MG/HR | film, extended release | Prescription | TRANSDERMAL | AB2 | Oct 30, 1998 |
| 0.2MG/HR | film, extended release | Prescription | TRANSDERMAL | AB2 | Oct 30, 1998 |
| 0.1MG/HR | film, extended release | Prescription | TRANSDERMAL | AB2 | Oct 30, 2017 |
| 0.6MG | tablet | Discontinued | SUBLINGUAL | N/A | Mar 8, 2022 |
| 0.4MG | tablet | Discontinued | SUBLINGUAL | N/A | Mar 8, 2022 |
| 0.3MG | tablet | Discontinued | SUBLINGUAL | N/A | Mar 8, 2022 |